| abstract |
(57) [Summary]nThe levovirin prodrug forms of the invention include a bioreversible modification at the sugar moiety and / or a bioreversible modification at the triazole moiety. The prodrug forms contemplated by the present invention can be used as pharmaceutical compositions, which can be used to treat infections, invasions, neoplasms or autoimmune diseases. Further, the uses contemplated by the present invention include the modulation of immunomodulation, particularly the expression of type 1 and type 2 cytokines. |